Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Depreciation Expense (2016 - 2025)

Prestige Consumer Healthcare has reported Depreciation Expense over the past 15 years, most recently at $2.4 million for Q4 2025.

  • For Q4 2025, Depreciation Expense rose 28.04% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $10.4 million, up 16.75%, while the annual FY2025 figure was $9.7 million, 18.29% up from the prior year.
  • Depreciation Expense for Q4 2025 was $2.4 million at Prestige Consumer Healthcare, down from $2.5 million in the prior quarter.
  • Over five years, Depreciation Expense peaked at $3.9 million in Q1 2021 and troughed at $1.8 million in Q3 2021.
  • A 5-year average of $2.2 million and a median of $2.0 million in 2023 define the central range for Depreciation Expense.
  • Biggest five-year swings in Depreciation Expense: surged 261.34% in 2021 and later crashed 54.43% in 2022.
  • Year by year, Depreciation Expense stood at $1.8 million in 2021, then increased by 3.6% to $1.9 million in 2022, then rose by 7.38% to $2.0 million in 2023, then decreased by 5.03% to $1.9 million in 2024, then increased by 28.04% to $2.4 million in 2025.
  • Business Quant data shows Depreciation Expense for PBH at $2.4 million in Q4 2025, $2.5 million in Q3 2025, and $2.5 million in Q2 2025.